Advent International Corp, one of the world’s largest private equity firms, is set to purchase a controlling stake in India’s Suven Pharmaceuticals Ltd for at least 63.13 billion rupees (US$763.7 million), triggering an open offer to buy further shares in the family-run firm.
The buyout firm agreed to acquire 50.1 percent of Suven from the Jasti family, an exchange filing yesterday showed.
The stake purchase also set off a mandatory offer to minority shareholders from Advent under which it can buy as many as 66.19 million shares — or another 26 percent stake — for 495 rupees each, the same price it is paying the founders for the majority stake.
Suven’s stock rose by 4.9 percent during trading in Mumbai yesterday before paring almost all of those gains to trade at 497 rupees. India’s benchmark S&P BSE Sensex advanced by 0.8 percent.
“Our vision for Suven is to build a US$1 billion global leader, by executing effectively on the product pipeline, building new marquee customers, turbo-charging business development and scaling up manufacturing and R&D,” Advent managing director Pankaj Patwari said.
The firm would look to acquire other global businesses “to build capabilities and gain new customers’ access,” he added.
For Advent, which has made more than 50 healthcare investments in 16 countries over the past three decades, the Suven deal adds to its growing portfolio in India, where it has bought majority stakes in engineering services company Encora and consumer durables firm Eureka Forbes.
Advent would also explore a potential merger of Suven, which is based in the Indian pharmaceutical hub of Hyderabad, with its portfolio firm, Cohance Lifesciences Ltd, to build a company specialized in contract development, manufacturing and active pharmaceutical ingredients.
The rout in global stocks has kept the head of Advent’s India business, Shweta Jalan, increasingly busy because more deals are being routed into the private-equity space, she said in May.
She has steered clear of India’s fintech space, where start ups are too early-stage or too expensive for her firm’s strategy, which leans toward investments in late-stage cash-generating businesses.
Advent’s key investment areas would continue to be healthcare, consumer, financial services and information technology in India, she said at the time.
Suven founder Venkateswarlu Jasti would be party to the deal announced yesterday, but would not be selling the 2,000 shares he holds.
Jasti would resign from the company’s board and as its managing director on completion of the deal, although he might provide some consultancy services as a chief adviser.
TEMPORARY TRUCE: China has made concessions to ease rare earth trade controls, among others, while Washington holds fire on a 100% tariff on all Chinese goods China is effectively suspending implementation of additional export controls on rare earth metals and terminating investigations targeting US companies in the semiconductor supply chain, the White House announced. The White House on Saturday issued a fact sheet outlining some details of the trade pact agreed to earlier in the week by US President Donald Trump and Chinese President Xi Jinping (習近平) that aimed to ease tensions between the world’s two largest economies. Under the deal, China is to issue general licenses valid for exports of rare earths, gallium, germanium, antimony and graphite “for the benefit of US end users and their suppliers
Nissan Motor Co has agreed to sell its global headquarters in Yokohama for ￥97 billion (US$630 million) to a group sponsored by Taiwanese autoparts maker Minth Group (敏實集團), as the struggling automaker seeks to shore up its financial position. The acquisition is led by a special purchase company managed by KJR Management Ltd, a Japanese real-estate unit of private equity giant KKR & Co, people familiar with the matter said. KJR said it would act as asset manager together with Mizuho Real Estate Management Co. Nissan is undergoing a broad cost-cutting campaign by eliminating jobs and shuttering plants as it grapples
Dutch chipmaker Nexperia BV’s China unit yesterday said that it had established sufficient inventories of finished goods and works-in-progress, and that its supply chain remained secure and stable after its parent halted wafer supplies. The Dutch company suspended supplies of wafers to its Chinese assembly plant a week ago, calling it “a direct consequence of the local management’s recent failure to comply with the agreed contractual payment terms,” Reuters reported on Friday last week. Its China unit called Nexperia’s suspension “unilateral” and “extremely irresponsible,” adding that the Dutch parent’s claim about contractual payment was “misleading and highly deceptive,” according to a statement
The Chinese government has issued guidance requiring new data center projects that have received any state funds to only use domestically made artificial intelligence (AI) chips, two sources familiar with the matter told Reuters. In recent weeks, Chinese regulatory authorities have ordered such data centers that are less than 30 percent complete to remove all installed foreign chips, or cancel plans to purchase them, while projects in a more advanced stage would be decided on a case-by-case basis, the sources said. The move could represent one of China’s most aggressive steps yet to eliminate foreign technology from its critical infrastructure amid a
RSS